Payers, Pharma Need “Talk Therapy” In Drug Pricing Dispute – Former Highmark CEO
This article was originally published in RPM Report
Executive Summary
Insurance experts discuss working with the pharmaceutical industry on solutions to paying for high-cost drugs, including risk sharing arrangements.